GlassScriptPhysician profile
Kamran Kamrava
NPI 1053483800
$7,250.74
in general payments reported to CMS, 2019-2025
26 companies · $537 in 2025
The $537 reported for 2025 was more than what 85% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,651 · 2020: $747 · 2021: $417 · 2022: $1,255 · 2023: $1,014 · 2024: $629 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,180.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,499.54 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $1,000.21 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $842.95 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $825.17 | 2019-2023 | Arexvy |
| Lilly USA, LLC | $535.06 | 2022-2024 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.51 | 2020-2024 | Jardiance |
| Cardiovascular Systems INC. | $220.68 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $149.36 | 2025 | |
| Amarin Pharma, INC. | $148.61 | 2020 | |
| Intuitive Surgical, INC. | $145.43 | 2020 | |
| Pfizer INC. | $135.63 | 2019 | |
| Abbott Laboratories | $128.09 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $124.92 | 2022 | |
| Kyowa Kirin, INC. | $123.46 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $122.07 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $120.45 | 2023 | |
| Axsome Therapeutics, INC. | $119.16 | 2025 | Symbravo |
| Esperion Therapeutics, INC. | $114.99 | 2021 | |
| Penumbra, INC. | $107.90 | 2023 | Penumbra System |
| Avanir Pharmaceuticals, INC. | $102.77 | 2019 | |
| Cook Medical LLC | $71.43 | 2019 | |
| Pulmonx Corporation | $59.45 | 2020 | |
| Alk-Abello, INC | $34.73 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.83 | 2025 | Lifevest |
| Sun Pharmaceutical Industries INC. | $20.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamran Kamrava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.